Glenmark confirms patent challenge for its generic version of FINACEA
Filed an ANDA for Azelaic Acid, Gel 15 per cent Topical, with US FDA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
ABLE celebrates its 10th anniversary
Charts biotech industry’s road map for the next decade by addressing the challenges and concerns. Shalini Gupta reports
EU Falsified Medicines Directive Industry proposes, Regulator disposes?
As the deadline for the implementation of the EU's Falsified Medicines Directive draws near, exporters of APIs to the EU and the…
Strategies for generic asthma inhalers: Copy or create?
Pharma companies around the world are looking for ways to address the global pulmonary drug delivery market and capitalise on long…
SC shoots down Novartis plea for Glivec patent
Experts stress that the verdict should not be seen as a case of weak IP rights
Digital Dose Exploring real time in Indian pharma
Dinesh Chindarkar, Co-founder, MediaMedic Communications kicks of series of articles titled ‘The Digital Dose for Indian Pharma’.
International technology transfer, FDI and development
Kamal Saggi, Professor of Economics, Vanderbilt University, gives an outlook about the strengths of Foreign Direct Investment,…